Global Tyrosine Kinase Inhibitor Market Report By Product (BCR-ABL, Tyrosine Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors And Other Tyrosine Kinase Inhibitors) Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer And Others) Distribution Channel (Hospital Pharmacies, Independent Pharmacies And Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210897
January 2020
Report Formats:

As per this study the Global Tyrosine Kinase Inhibitor Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.
 
Tyrosine kinase inhibitor is the drug that inhibits the activity of tyrosine kinase. Tyrosine kinase plays a vital role in cell signaling, growth, and division. The tyrosine kinase inhibitor acts as a targeted therapy for the malignant tumors and functions effectively by targeting cancer cells to die causing the least damage to the normal healthy cells and thus blocks the cancer growth.
 
Market Dynamics
 
The tyrosine kinase inhibitor market is experiencing remarkable growth owing to the rise in prevalence of cancer across the globe. Rising cancer diagnosis and treatment awareness campaigns along with an increase in healthcare expenditure are driving the market growth. In addition to this, factors such as poor eating habits, excessive smoking & drinking, changing lifestyles, and genetic mutations are further boosting the cancer prevalence. This is propelling market growth.    
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of tyrosine kinase inhibitor.
 
Market Segmentation
 
The broad tyrosine kinase inhibitor market has been sub-grouped into product, application and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • BCR-ABL, Tyrosine Kinase Inhibitors
  • Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
  • Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
  • Other Tyrosine Kinase Inhibitors
 
By Application
  • Chronic Myeloid Leukemia (CML)
  • Lung Cancer
  • Breast Cancer
  • Renal Cell Cancer
  • Others
 
By Distribution Channel
  • Hospital Pharmacies
  • Independent Pharmacies
  • Online Pharmacies
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for tyrosine kinase inhibitor in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Tyrosine Kinase Inhibitor Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the tyrosine kinase inhibitor market include AstraZeneca Plc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eurofarma Laboratórios S/A, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis AG, and Pfizer, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Tyrosine Kinase Inhibitor Market
       2.2. Global Tyrosine Kinase Inhibitor Market Snapshot
 
3 . TYROSINE KINASE INHIBITOR – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Tyrosine Kinase Inhibitor Market
       3.3. Market Restraints of Tyrosine Kinase Inhibitor Market
       3.4. Opportunities of Tyrosine Kinase Inhibitor Market
       3.5. Trends of Tyrosine Kinase Inhibitor Market
       3.6. Porter’s Five Force Analysis of Tyrosine Kinase Inhibitor Market
       3.7. Tyrosine Kinase Inhibitor Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Tyrosine Kinase Inhibitor Value Chain Analysis
       4.2. Tyrosine Kinase Inhibitor Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Tyrosine Kinase Inhibitor Raw Material Manufactures List
           4.2.3. Price Trend of Tyrosine Kinase Inhibitor Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Tyrosine Kinase Inhibitor Market Analysis by Product
       5.3 Market Analysis of BCR-ABL, Tyrosine Kinase Inhibitors by Regions
       5.4 Market Analysis of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors by Regions
       5.5 Market Analysis of Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors by Regions
       5.6 Market Analysis of Other Tyrosine Kinase Inhibitors by Regions
 
6 . GLOBAL TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Tyrosine Kinase Inhibitor Market Analysis by Application
       6.3 Market Analysis of Chronic Myeloid Leukemia (CML) by Regions
       6.4 Market Analysis of Lung Cancer by Regions
       6.5 Market Analysis of Breast Cancer by Regions
       6.6 Market Analysis of Renal Cell Cancer by Regions
       6.7 Market Analysis of Others by Regions
 
7 . GLOBAL TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Tyrosine Kinase Inhibitor Market Analysis by Distribution Channel
       7.3 Market Analysis of Hospital Pharmacies by Regions
       7.4 Market Analysis of Independent Pharmacies by Regions
       7.5 Market Analysis of Online Pharmacies by Regions
 
8 . GLOBAL TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Tyrosine Kinase Inhibitor Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Tyrosine Kinase Inhibitor Market Estimate by Market Segment
           8.4.3. Europe Tyrosine Kinase Inhibitor Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Market Segment
           8.5.3. Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Tyrosine Kinase Inhibitor Market Estimate by Market Segment
           8.6.3. Latin America Tyrosine Kinase Inhibitor Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Tyrosine Kinase Inhibitor Market Estimate by Market Segment
           8.7.3. Middle East & Africa Tyrosine Kinase Inhibitor Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE TYROSINE KINASE INHIBITOR COMPANIES
       9.1. Tyrosine Kinase Inhibitor Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF TYROSINE KINASE INHIBITOR INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AstraZeneca Plc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bayer AG
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Boehringer Ingelheim International GmbH
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bristol-Myers Squibb Company
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Eisai Co., Ltd.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Eurofarma Laboratórios S/A
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. F. Hoffmann-La Roche Ltd.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Johnson & Johnson
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Novartis AG
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Pfizer, Inc.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Tyrosine Kinase Inhibitor Market Snapshot
  • Drivers of The Global Tyrosine Kinase Inhibitor Market Impact Analysis
  • Restraints of The Global Tyrosine Kinase Inhibitor Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in BCR-ABL, Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Other Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis by Application (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Chronic Myeloid Leukemia (CML) by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Renal Cell Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Others by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Independent Pharmacies by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market by Geography (USD MN)
  • North America Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • North America Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • North America Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • North America Tyrosine Kinase Inhibitor Market Estimate by Country (USD MN)
  • United State Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • United State Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • United State Tyrosine Kinase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Rest of North America Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Rest of North America Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel(USD MN)
  • Europe Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Europe Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Europe Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • United Kingdom Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • United Kingdom Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • France Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • France Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • France Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Germany Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Germany Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Germany Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Rest of Europe Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Rest of Europe Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Country (USD MN)
  • China Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • China Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • China Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Japan Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Japan Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Japan Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • India Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • India Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • India Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Latin America Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Latin America Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Latin America Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Latin America Tyrosine Kinase Inhibitor Market Estimate by Country (USD MN)
  • Brazil Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Brazil Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Brazil Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Rest of Latin America Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Rest of Latin America Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Middle East & Africa Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Middle East & Africa Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Tyrosine Kinase Inhibitor Market Estimate by Country (USD MN)
  • Middle East Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Middle East Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Middle East Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Africa Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Africa Tyrosine Kinase Inhibitor Market Estimate by Application (USD MN)
  • Africa Tyrosine Kinase Inhibitor Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Tyrosine Kinase Inhibitor Report
  • Market Research Process
  • Market Research Methodology
  • Global Tyrosine Kinase Inhibitor Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Tyrosine Kinase Inhibitor Market Analysis by Product (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in BCR-ABL, Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Other Tyrosine Kinase Inhibitors by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis by Application (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Chronic Myeloid Leukemia (CML) by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Renal Cell Cancer by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Others by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis by Distribution Channel (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Independent Pharmacies by Geography (USD MN)
  • Global Tyrosine Kinase Inhibitor Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Tyrosine Kinase Inhibitor Market by Revenue
  • Middle East & Africa Tyrosine Kinase Inhibitor Market by Revenue
  • Recent Development in Tyrosine Kinase Inhibitor Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials